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Abstract
Background: The increased levels of blood cytokines is the main immunopathological process that were attributed
to severe clinical outcomes in cases of influenza A, influenza B and people with influenza-like illness (ILI). Functional
genetic polymorphisms caused by single nucleotide polymorphisms (SNPs) in inflammatory cytokines genes can
influence their functions either qualitatively or quantitatively, which is associated with the possibility of severe
influenza infections. The aim of the present case-control study was to investigate the association of polymorphisms
in inflammatory cytokines genes with influenza patients and ILI group in an Iranian population.
Methods: Total number of 30 influenza B, 50 influenza A (H1N1) and 96 ILI inpatient individuals were confirmed by
Real-time RT-PCR and HI assays. The genotype determination was assessed for defined SNPs in IL-1β, IL-17, IL-10
and IL-28 genes.
Results: The frequencies of the IL-1β rs16944 (P = 0.007) and IL-17 rs2275913 (P = 0.006) genotypes were associated
with severe influenza disease, while the frequencies of IL-10 rs1800872 and IL-28 rs8099917 were not associated
with the disease (P > 0.05). Also, the absence of A allele in IL-17 rs2275913 SNP increased the risk of influenza A
(H1N1) infection (P = 0.008).
Conclusions: This study demonstrated that influenza A- (H1N1) and B-infected patients and also ILI controls have
different profiles of immune parameters, and individuals carrying the specific cytokine-derived polymorphisms may
show different immune responses towards severe outcome.
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Background
Influenza viruses are known as worldwide human and
livestock pathogens which have caused serious respira-
tory diseases and deaths over the past century [1–3]. In-
fluenza viruses have always had potential to cause
widespread pandemics whenever several risk factors
including live poultry market, climatic factors and most
importantly susceptibility of type A to high diversity upon
combination of different pathogenic hemagglutinins (HA)
and neuraminidases (NA) proteins are available [4, 5].
Since H1N1 has been known as responsible for 2009 pan-
demic, upon evaluation of the 3672 confirmed cases of
influenza A (H1N1) in Iran between 22 May and 21 De-
cember 2009, Gouya and colleagues reported that infec-
tions occurred in all age groups with and without any
predisposing factors [6]. Further, according to the data ob-
tained from www.who.int/flunet, and even in Iran [7],
influenza B activity remained low, however, in East Asia
high levels of influenza activity were reported which need
more and more attentions.
Besides smoking, pregnancy and obesity risk factors,
host immune conditions such as dysregulation in
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systemic anti- and pro-inflammatory responses also
affect influenza primary infections. Although, the in-
fected cells produce cytokines for the initiation of an
immune response as well as controlling viral replication,
influenza infection causes hypercytokinaemia which re-
sults in extra-respiratory tissue destruction following
serious complications, disease development and death
[8]. High levels of transcription, production and func-
tional activity of inflammatory or anti-inflammatory
cytokines sometimes originate from genetic variation
such as single nucleotide polymorphisms (SNPs), altered
coding region and promoter or regulatory region of cy-
tokines genes. Further, SNPs in certain alleles of pro-
inflammatory cytokines resulted in susceptibility to a
wide range of infections [9]. Regarding these cytokines,
endothelial cells secrete Interleukin-1β (IL-1β) through
NLRP3 inflammasome mechanisms that contribute to
flu-induced inflammation in lung cells [10]. One of the
typical functional SNPs was found in IL-1B promoter,
T-to-C transition at situation − 31 (rs16944). It is lo-
cated in a TATA-box motif of IL-1B and affects the
transcription activity of IL-1B through binding of
multiple transcription factors [11]. It has been shown
that an increase in IL-1β cytokine causes lung damage
during infection by influenza A [12]. A study showed
rs16944 polymorphism in IL-1β contribution to an in-
creased risk of gastric cancer with proinflammatory
phenotype in Caucasian carriers [12]. Another study
highlighted the association of IgAN (IgA nephropathy;
the most common form of primary glomeruloneph-
ritis) with upper respiratory tract infections [13].
Also, deficiency or variation of interleukin-17 (IL-17),
a cytokine mainly secreted by Th17 cells, has caused in-
creased susceptibility to the infection of extracellular
pathogens [14]. Exclusively, the rs2275913 SNP that is
located in promoter of the IL-17A gene is associated
with a lot of diseases. It has been reported that the pres-
ence of A allele at the rs2275913 SNP increases the se-
cretion of IL-17A [15, 16]. A meta-analysis study
showed that IL-17A rs2275913 polymorphism is remark-
ably linked to the risk of many types of cancer [17]. A
recent study showed that rs2275913 SNP of the IL-17
gene is related to acute bronchiolitis severity and this
SNP could lead to variations in IL-17 expression [18].
One of the other most important responses to viral
respiratory infections in airway cells is interferon se-
cretion; however, there is little information about the
polymorphisms associated with the gene IL-28 and
the disease outcome [19]. The SNP polymorphisms
located at rs8099917 site near the interleukin (IL)
28B gene as a type III interferon group is associated
with spontaneous clearance of or a sustained viro-
logical response to interferon (IFN) α and ribavirin
treatment in hepatitis C virus (HCV) patients [20–
22]. The rs8099917 was also shown to be associated
with natural clearance of HCV [23].
IL-10 is a key component of anti-inflammatory cyto-
kine systems that regulates and suppresses the expres-
sion of pro-inflammatory cytokines by macrophages to
limit the damage caused by viral and bacterial infections
[24]. In this context, the frequencies of the certain SNPs
in IL-10 alleles in Mexican patients were associated with
susceptibility to severe disease, while other SNPs were
associated with protection from severe disease [25].
The rs1800872 polymorphism that is located at the 5′-
flanking region of IL-10 promoter is related to increased
intensity of autoimmune and infectious diseases and
control the transcription and expression of IL-10 [26,
27]. Schuurhof et al., showed that rs1800872 SNP en-
hanced resistance to severe Respiratory Syncytial Virus
(RSV) infection and IL-10 balance could reduce the
harmful effects of the immune system [28]. The IL-10
rs1800872 was shown to contribute to an increased risk
for virus-induced encephalitis as well [29]. Therefore,
evaluation of all these polymorphisms in relation to in-
fluenza disease is of great importance.
Viruses take advantage of SNPs-driven variations in
host cytokines that alter the transcriptional activity of
their genes as well as association with the possibility of a
wide range of influenza viruses [30]. Another challenge
is monitoring or classifying people with influenza-like ill-
ness [31] that frequently occur after influenza virus vac-
cination. The immunological response which is
determined by blood cytokines are different in these
cases [32]. Therefore, evaluation of the secreted cyto-
kines and their SNP variants might be important. Re-
cently study by Rogo and colleagues reported the effects
of defined SNPs in IL-1β, IL-10, IL-17, and IL-28 in flu
A/H3N2 in Iranian population that showed a higher risk
of developing a severe infection [33]. However, to the
best of our knowledge, the profile and the role of these
certain SNPs have not been identified in cases of flu A/
H1N1 and B infected Iranian patients. Regarding this,
the present study was performed to investigate the SNPs
in IL-1β, IL-10, IL-17, and IL-28 in severe cases of flu
A/H1N1- and B-infected patients and compare the out-
come with ILI cases in an Iranian population.
Methods
Study design
We performed a case–control study on the specimens
obtained from the National Influenza Centre, Tehran
University of Medical Sciences (TUMS) from February
2017 to March 2017. Total number of individuals who
participated in the study include: 30 influenza B positive,
50 influenza A (H1N1) positive and 96 ILI cases. Pa-
tients with severe influenza infection were approved by a
positive viral test and ILI subjects were negative in terms
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of influenza tests. All the tests were repeated twice. In-
fluenza patients and ILI cases were defined with the
symptoms: fever> 38 °C, sore throat, cough, rhinorrhea,
dyspnea, headache, vomiting, thoracic pain and anorexia.
Written consent was acquired from all contributors and
approved by Science and Bioethics committee of Tehran
University of Medical Sciences.
Viral RNA extraction and molecular detection
Viral RNA was extracted from 200 μl fluid samples by
High Pure Viral Nucleic Acid kit (Roche, Germany) ac-
cording to the manufacturer’s manual. Then, Real-time
RT-PCR was performed by RT-PCR kit (QIAGEN,
Germany) using specific primers and probes in Stepone
pulse instruments (Applied Biosystems, Foster City, CA)
according to the protocol. The primer sequences used to
identify subtypes of influenza A/H1N1 and B are listed
in Table 1.
Genotyping of SNPs
DNA from each specimen (serum) was extracted using
Roche DNA purification kit (Roche, Germany) according
to the manufacturer’s instructions. After extraction,
genotype determination was carried out for polymor-
phisms in IL-1b rs16944, IL-10 rs1800872, IL-17
rs2275913, and IL-28 rs8099917 using TaqMan commer-
cial probes (Applied Biosystems, Foster City, CA). Gen-
etic information related to the SNPs is provided in
Table 2. For Real Time RT-PCR all reactions were car-
ried out with 10 μl of TaqMan SNP genotyping master
mix (Life Technology, Carlsbad, CA), 0.2 μl of probes,
4.8 μl distilled water, 5 μl of DNA samples. The cycling
temperature was selected as follow: 95 °C for 10 min, 40
cycles of 95 °C for 15 s, and 60 °C for 1 min.
Statistical analysis
Statistical analysis was performed using Software pack-
ages SPSS 19 (IBM, Chicago, IL) and concordance be-
tween the two tests was determined using Chi-square
(x2) test. *: P < 0.05, **: P < 0.01 and ***: P < 0.001.
Results
Participants
A total of 50 influenza A (H1N1), 30 influenza B and 96
ILI were participated in this study. The mean age for in-
fluenza A, influenza B and ILI cases were 37.18 ± 21.49
(1–86), 47 ± 20.2 (4–76) and 48.6 ± 25.8 (1–90) years, re-
spectively. In respect to age groups; 7 (14%) of influenza
A (H1N1), 4 (13%) of influenza B groups and 16 (15%)
of ILI cases were aged less than 20 years. About 34
(68%) of influenza A (H1N1), 15 (50%) of influenza B
groups and 45 (46%) of ILI cases were aged 20–60 years
and 9 (18%) of influenza A (H1N1), 11 (36%) of influ-
enza B, and 33 (34%) of ILI were aged > 60 years. In in-
fluenza A patients 28 (56%) were male and 22 (44%)
were female, in influenza B group 14 (46%) were male
and 16 (53%) were female and in ILI group 42 (43%) and
52 (54%) were male and female, respectively (Table 3).
Table 1 Real-time PCR primers and probes specifications
Primers/Probes Sequence (5′ > 3′)
Flu A Forward GACAAAATAACATTCGAAGCAACTGG
Flu A Reverse GGGAGGCTGGTGTTTATAGCACC
Flu A Probea GCATTCGCAA″t″GGAAAGAAATGCTGG
Flu B Forward TCCTCAAYTCACTCTTCGAGCG
Flu B Reverse CGGTGCTCTTGACCAAATTGG
Flu B Probeb CCAATTCGAGCAGCTGAAACTGCGGTG
aTaqMan probes are labeled at 5′- end with FAM and at the 3′- end with BHQ1
bTaqMan probes are labeled at 5′- end with ROX and at 3′- end with BHQ1
Table 2 The analyzed SNPs genetic data used in the study
Gene
(SNP)
Target Location Alleles Context sequence
rs16944 IL-1β Chr2:
113594867
G/A TACC
TTGGGTGCTGTTCTCTGCCTC[G/
A]
GGAG
CTCTCTGTCAATTGCAGGAGC
rs1800872 IL-10 Chr1:
206946407
T/G CTTT
CCAGAGACTGGCTTCCTACAG[T/
G]
ACAG
GCGGGGTCACAGGATGTGTTC
rs2275913 IL-17 Chr 6:
52051033
A/G TGCC
CTTCCCATTTTCCTTCAGAAG[A/
G]
AGAG
ATTCTTCTATGACCTCATTGG
rs8099917 IL-28 Chr 19:
39743165
G/T TTTT
GTTTTCCTTTCTGTGAGCAAT[G/
T]
TCAC
CCAAATTGGAACCATGCTGTA
Table 3 Demographic information of participated patients in
this study
Group Age (%) Sex (%) Total (%)
Influenza A (H1N1) <= 20: 7 (14)
21–60: 34 (68)
> 60: 9 (18)
Male: 28 (56)
Female: 22 (44)
50 (28.4)
Influenza B <= 20: 4 (13.3)
21–60: 15 (50)
> 60: 11 (36.7)
Male: 14 (46.7)
Female: 16 (53.3)
30 (17)
ILI <= 20: 16 (15.6)
21–60: 45 (46.9)
> 60: 33 (34.4)
Male: 42 (44.7)
Female: 52 (55.3)
93(54.5)
Total <= 20: 26 (14.8)
21–60: 94 (53.4)
> 60: 53 (30.1)
Male: 84 (48.3)
Female: 90 (51.7)
174 (100)
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Also, the frequency of clinical symptoms in influenza A
(H1N1) and B groups are indicated in Table 4.
Genotyping
The allele and genotype frequencies for SNPs in IL-1β,
IL-10, IL-17 and IL-28, are shown in Table 5. The ana-
lysis of genotype variation in influenza A (H1N1), influ-
enza B and ILI groups demonstrated that the
frequencies of AA, GA, GG genotypes of IL-1β (p =
0.008) and IL17 (p = 0.024) could be associated with the
risk of flu infections, while no significant association
were found in the SNP genotypes of IL-10 and IL-28.
The results showed that in comparison with ILI group,
genotypes AA, GA, GG of IL-17; rs2275913 in influenza
A (H1N1) were statistically significant and associated
with the risk of influenza infection (p = 0.007) (Table 6).
Also, in comparison with ILI group, the genotypes AA,
GA, GG of IL-1β; rs16944 in influenza B group were sta-
tistically significant, which were associated with the risk
of influenza infection (p = 0.014) (Table 7).
The comparison of genotype variation in influenza
groups (A and B) versus ILI group revealed that the ge-
notypes AA, GA, GG of IL-1β; rs16944 and AA, GA,
GG of IL-17; rs2275913 were statistically significant and
associated with the risk of influenza infection, (p =
0.007) and (p = 0.006), respectively (Table 8). On the
other hand, the frequency of A, G, and T alleles were
evaluated in influenza A and B, and ILI groups. The re-
sults showed that the absence of alleles A in IL-17;
rs2275913 SNP increases the risk of influenza A (H1N1)
infection (p = 0.008) (Table 6).
Discussion
In this case-control study, samples were obtained from
50 influenza A (H1N1), 30 influenza B and 96 ILI pa-
tients. All the patients and ILI cases were confirmed
using molecular and serological assays (Real-time RT-
PCR and hemagglutination inhibition), respectively. The
ILI patients were negative for the influenza viruses by
these tests. They also had no history of vaccination and
chronic diseases like chronic obstructive pulmonary dis-
ease (COPD).
The immune response to influenza virus infection is
the production of inflammatory mediators like chemo-
kines, proinflammatory and regulatory cytokines. This
response contributes to the pathogenesis and severity of
influenza infection. Sometimes a cytokine storm leads to
the bronchiolitis and alveolar edema which are the char-
acteristics of severe influenza outcome [34]. A study on
pediatric outpatients infected with influenza, identified a
Table 4 Clinical symptoms of influenza-infected patients
Groups Fever Sore throat Cough Rhinorrhea Dyspnea Nasal congestion Thoracic pain Headache Anorexia Vomiting
Flu A (H1N1) 50 (100%) 34 (68%) 44 (88%) 25 (50%) 25 (50%) 46 (92%) 18 (36%) 34 (68%) 17 (34%) 15 (30%)
Flu B 30 (100%) 21 (70%) 25 (83%) 13 (43%) 18 (60%) 27 (90%) 12 (40%) 23 (76%) 13 (43%) 7 (23%)
Table 5 Genotype frequencies of IL-β, IL17, IL10 and IL28 in influenza A (H1N1), influenza B and ILI groups
Gene and genotype Flu A (H1N1) (%) Flu B (%) ILI (%) Crude p value
IL-1β; rs16944
AA 6(19.4) 1(3.2) 24(77.4)
GA 44(31.9) 27(19.6) 67(48.6) .008*
GG 0(0) 2(33.3) 4(66.7)
IL-17; rs2275913
AA 3(20) 3(20) 9(60)
AG 16(20) 10(12.5) 54(67.5) .024*
GG 30(32.5) 14(18.4) 32(42.1)
IL-10; rs1800872
GG 3(37.5) 1(3.2) 4(50)
TG 44(29.5) 27(19.6) 77(51.7) .944
TT 3(27.3) 2(33.3) 7(63.6)
IL-28; rs8099917
GG 2(33.3) 0 4(66.7)
GT 28(31.1) 14 48(53.3) .757
TT 20(25.3) 16 43(54.4)
p value is significant
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proinflammatory cytokine profile that was associated
with symptom severity [35]. It has been highlighted that
specific cytokine and chemokine inhibitors may have the
potential for severe influenza virus infection [36].
According to the pervious study, delivery of influenza
viruses into the lung of hosts is associated with the pro-
duction of pro-inflammatory cytokines and induction of
pneumonia [37], hence it is concluded that increased cy-
tokines production during viral infection plays an im-
portant role in the viral pathogenesis and disease
development. Further, the presence of SNPs within the
coding or promoter regions of cytokine genes can influ-
ence the degree of cytokine expression [38].
In this regard, some studies suggested that SNPs in
the IL-10 and IL-1β genes might be associated with the
severe outcome in influenza outbreak [39, 40]. Also, an-
other study demonstrated that polymorphisms of L-1β,
IL-10, IL-17, and IL-28 genes involved in the inflamma-
tory process affect the outcome of disease caused by in-
fluenza A/H3N2 virus [33].
Previous studies on polymorphisms in interleukin
genes have shown association with the susceptibility to
Table 6 Genotype and allele frequencies of IL-β, IL17, IL10 and IL28 in influenza A (H1N1) and ILI groups
Gene and genotype/ Allele Flu A (H1N1) (%) ILI (%) Crude p value OR (95% CI) Adjusted P value
IL-1β; rs16944
AA 6(20) 24(80)
GA 44(39.6) 67(60.4) .057 .185
GG 0(0) 4(100)
GG vs. GA/AA 0(0) 50(35.5) 4(100) 91(64.5) .299 .000 (.000- NA) .999
AA vs. GG/GA 6(20) 44(38.3) 24 (80) 71(61.7) .061 .295 (.103–.845) .023
A 56 (56) 115 (60) .456 1.205(.738–1.967)
G 44 (44) 75 (39)
IL-17;rs2275913
AA 3(25) 9(75)
AG 16(22.9) 54(77.1) .007* .011*
GG 30(48.4) 32(51.6)
GG vs. GA/AA 30(48.4) 19(23.2) 32(51.6) 63(76.8) .002* 3.072 (1.461–6.461) .003*
AA vs. AG/GG 3(25) 46(34.8) 9(75) 86(65.2) .491 .635 (.154–2.621) .530
A 22 72 .008* 2.108(1.207–3.682)
G 76 118
IL-10; rs1800872
GG 3(42.9) 4(57.1) .851
TG 44(36.4) 77(63.6) .575
TT 3(30) 7(70)
TT vs. GG/TG 3(30) 47(36.7) 7(70) 81(63.3) .670 .774 (.183–3.277) .728
GG vs. TG/TT 3(42.9) 47(35.9) 4(57.1) 84(64.1) .704 .810 (.165–3.974) .795
T 50 91 .785 1.071(.655–1.749)
G 50 85
IL-28; rs8099917
GG 2(33.3) 4(66.7)
GT 28(36.8) 48(63.2) .863 .683
TT 20(31.7) 43(68.3)
TT vs. GG/GT 20(31.7) 30(36.6) 43(68.3) 52(63.4) .543 .658 (.316–1.372) .264
GG vs. GT/TT 2(33.3) 48(34.5) 4(66.7) 91(65.5) 1.000 1.228 (.206–7.323) .821
T 68 134 .656 1.126(.667–1.900)
G 32 56
OR Odds ratio, CI Confidence interval (calculated by logistic regression model)
p value is significant
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flu infection due to their influence on cytokine produc-
tion. Here, we evaluated the polymorphisms of several
pro-inflammatory genes in severe influenza A (H1N1), B
cases and ILI patients. Based on the WHO case defin-
ition, all flu positive cases in our study were already di-
agnosed and confirmed as severe acute respiratory
infections (SARI) and required hospitalization (https://
www.who.int/influenza/surveillance_monitoring/ili_sari_
surveillance_case_definition/en/).
A study by Joel Martinez-Ocana et al. [25], demon-
strated that IL-10 production in all viral-infected pa-
tients were elevated, and another study claimed that
genotypes GG and TG of IL-10 (rs1800872) had signifi-
cant association with the increased risk of severe influ-
enza infection, however, in our study IL-10 SNPs in
three patient groups did not show any association with
viral infection or ILI (Tables 6, 7 and 8). It should be
noted that, the type of selected SNP, time of sample col-
lection, and nationality might affect the host responses
and analysis results. In contrast, the frequencies of the
IL-10 − 592C in Mexican patients during the influenza
pandemic A(H1N1) pdm09 infection were associated
with susceptibility to severe disease [25]. Addressing the
nationality, a study showed that the IL-10; rs1800872
Table 7 Genotype and allele frequencies of IL-β, IL17, IL10 and IL28 in influenza B and ILI groups
Gene and genotype/Allele Flu B (%) ILI (%) Crude p value OR (95%CI) Adjusted P value
IL-1β; rs16944
AA 1(4) 24(96)
GA 27(28.7) 67(71.3) .014* .026*
GG 2(33.3) 4(66.7)
GG vs. GA/AA 2(33.3) 28(23.5) 4(66.7) 91(76.5) .629 1.549 (.266 9.007) .626
AA vs. GG/GA 1(4) 29(29) 24(96) 71(71) .009* .101 (.013–.786) .029
A 29 115 .096 1.639(.914–2.939)
G 31 75
IL-17; rs2275913
AA 3(25) 9(75) .176 .305
AG 10(15.6) 54(84.4)
GG 14(30.4) 32(69.6)
GG vs. GA/AA 14(30.4) 13(17.1) 32(69.6) 63(82.9) .086 2.031 (.851 4.849) .111
AA vs. AG/GG 3(25) 24(21.8) 9(75) 86(78.2) .801 1.227 (.301–4.994) .775
A 16 72 .264 1.449(.754–2.786)
G 38 118
IL-10; rs1800872
GG 1(20) 4(80) .871 .634
TG 28(26.7) 77(73.3)
TT 1(12.5) 7(87.5)
TT vs. GG/TG 1(12.5) 29(26.4) 7(87.5) 81(73.6) .385 .391 (.046–3.353) .391
GG vs. TG/TT 1(20) 29(25.7) 4(80) 84(74.3) 1.000 .631 (.065–6.127) .691
T 30 91 .820 1.071(.596–1.924)
G 30 85
IL-28; rs8099917
GG 0(0) 4(100) .244
GT 14(22.6) 48(77.4) .588
TT 16(27.1) 43(72.9)
TT vs. GG/GT 16(27.1) 14(21.2) 43(72.9) 52(78.8) .440 1.314 (.5693.036) .522
GG vs. GT/TT 4(100) 91(75.2) 0(0) 30(24.8) .572 .000 (.000 - NA) .999
T 46 134 .356 .728(.371–1.430)
G 14 56
OR Odds ratio, CI Confidence interval (calculated by logistic regression model)
p value is significant
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was associated with the increased risk of infection with
influenza A/H3N2 virus in Iranian population [33].
However, this SNP in the current study on the Iranian
patients with flu A and B and ILI was not associated
with significant flu infection or ILI groups (Tables 5, 6, 7
and 8). It reveals that apart from host immune re-
sponses, the subtype of flu viruses may be involved in
different genotype variation expression.
IL-28, a member of the IFN-γ family with antiviral prop-
erties in consistent with IL-10 induce survival signaling in
host cells. Pervious study showed the transplant patients
who carry minor-alleles in the IL-28B gene (rs8099917, TG
or GG) have significantly higher rates of seroconversion fol-
lowing influenza vaccination [41]. Our data in Tables 6, 7
and 8 showed that at rs8099917, TT is the major-allele and
TG or GG are minor-allele genotypes, hence patients with
minor-allele genotypes of IL-28B may be strongly associ-
ated with the immunosuppressive responses and host pro-
tection. Therefore, similar to IL-10, in the present study, we
found that IL-28; rs8099917 SNPs were not associated with
the severe influenza infections (P > 0.05) (Tables 6, 7 and 8)
. In contrast, two previous studies demonstrated that IL-28;
rs8099917 SNPs developed flu A (H3N2) and HCV infec-
tions in Iranian and Italian patients, respectively [33, 42].
Table 8 Genotype and allele frequencies of IL-β, IL17, IL10 and IL28 in influenza (A & B) and ILI groups
Gene and genotype Flu A & B (%) ILI (%) Crude p value OR (95% CI) Adjusted p value
IL-1β; rs16944
AA 7(22.6) 24(77.4)
GA 71(51.4) 67(48.6) .007*
GG 2(33.3) 4(66.7) .027*
GG vs. GA/AA 2(33.3) 78(46.2) 4(66.7) 91(53.8) .689 .547 (.096–3.127)
AA vs. GG/GA 7(22.6) 73(50.7) 24 (77.4) 71(49.3) .004* .235 (.091–.610)
A 85 115 .163 1.353 (.884–2.070)
G 75 75
IL-17; rs2275913
AA 6(40) 9(60)
AG 26(32.5) 54(67.5) .006* .019*
GG 44(57.9) 32(42.1)
GG vs. GA/AA 44(57.9) 32(33.7) 32(42.1) 63(66.3) .002* 2.589 (1.3714.889)
AA vs. AG/GG 6(40) 70(44.9) 9(60) 86(55.1) .717 .810 (.266–2.467)
A 38 72 .011* 1.831 (1.144–2.928)
G 114 118
IL-10; rs1800872
GG 4(50) 4(50) .760
TG 72(48.3) 77(51.7)
TT 4(36.4) 7(63.6) .510
TT vs. GG/TG 4(36.4) 76(48.4) 7(63.6) 81(51.6) .439 .619 (.170–2.256)
GG vs. TG/TT 4(50) 76(47.5) 4(50) 84(52.5) 1.000 .731 (.168–3.178)
G 80 85 .755 .934 (.609–1.433)
T 80 91
IL-28; rs8099917
GG 2(33.3) 4(66.7)
GT 42(46.7) 48(53.3) .889
TT 36(45.6) 43(54.4) .784
TT vs. GG/GT 36(45.6) 44(45.8) 43(54.4) 52(54.2) .972 .882 (.474–1.641)
GG vs. GT/TT 2(33.3) 78(46.2) 4(66.7) 91(53.8) .68 .669 (.116–3.841
G 46 56 .882 1.036 (.652–1.646)
T 114 134
OR Odds ratio, CI Confidence interval (calculated by logistic regression model)
p value is significant
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Additionally, in the present study, we found that through
comparison of SNPs frequency of flu A-, flu B- and flu A +
B- infected patients with ILI group, the IL-1β and IL-17 ge-
notypes (GG, GA and AA) might be associated with the se-
vere influenza infection. Several studies have shown that
children and mice infected with H1N1 influenza, presented
more severe clinical manifestations and expressed high level
of IL-1β cytokine compared to the control group with mild
clinical manifestations [37, 43]. In our study, genotype AA
of IL-1β; rs16944 was shown (Tables 6, 7 and 8) to have sig-
nificant association with influenza severe infection. Indeed,
genotype AA in IL-1β; rs16944 protects patients against in-
fluenza B infection. These results were inconsistent with
two studies that showed the IL-1β polymorphism AA ver-
sus GG/AG enhanced susceptibility to invasive flu A
(H3N2) and mild infection after solid organ transplantation,
respectively [33, 44].
The IL-17 cytokine is known with diverse functions,
which any deregulation in IL-17 production results in
the host progression of cancers, inflammatory dis-
eases, autoimmune disorders, and clearance of viral
or microbial pathogens [45–47]. In respect to this
context, besides SNP and IL types, addressing the
type of alleles shows that the presence of G allele in
IL-17; rs2275913 SNP increases the risk of influenza
A (H1N1) infection (P = 0.008) (Table 5). In contrast,
high frequency of these alleles in other evaluated
SNPs, suggested that sometimes these variations may
be associated with the regulation of the immune re-
sponses as well as protection against severe infection.
These data suggest that patients carrying allele “A” at
position IL-17; rs2275913 lack the ability to control
their inflammatory response which results in ineffect-
ive immune T cells responses against flu viral infec-
tion. Furthermore, similar to the findings of two other
studies, H1N1 pandemic influenza virus induced Th17-
secreted IL-17, which mediated the evolution of H1N1
mild and severe diseases [48, 49]. This data demonstrated
that flu viruses benefitted from IL-17 SNPs towards devel-
oping their infection and lung injury.
Conclusions
In conclusion, understanding and evaluation of the pat-
terns of cytokine co-variation especially in regards to dif-
ferent SNPs would provide novel insights into the
pathophysiology and severity of the disease. The data
obtained from the current study, showed that genotypes
GG and AA of IL-17; rs2275913 and IL-1β; rs16944, re-
spectively might be associated with severity of influenza
A/H1N1 and B infections but IL-10; rs1800872 and IL-
28; rs8099917 SNPs did not show any association with
the risk of infection.
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